Showing results (751-760 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|December 5, 2000
Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese childrenH Takahashi, S Ishikawa, S Nomoto, et al.Clinical Pharmacology and Therapeutics|December 1, 1999
The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivoR A Mirghani, U Hellgren, P A Westerberg, et al.Clinical Pharmacology and Therapeutics|December 1, 1999
Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilationS C Romerio, L Linder, W E HaefeliClinical Pharmacology and Therapeutics|May 29, 2000
Nicotine metabolism and elimination kinetics in newbornsD Dempsey, P Jacob, N L BenowitzClinical Pharmacology and Therapeutics|May 29, 2000
Investigations of the metabolites of the trypanocidal drug melarsoprolJ Keiser, O Ericsson, C BurriClinical Pharmacology and Therapeutics|May 29, 2000
The influence of reduced liver blood flow on the pharmacokinetics and pharmacodynamics of recombinant tissue factor pathway inhibitorM J Kemme, J Burggraaf, R C Schoemaker, et al.Clinical Pharmacology and Therapeutics|December 5, 2000
Myocardial efficiency during levosimendan infusion in congestive heart failureH Ukkonen, M Saraste, J Akkila, et al.Clinical Pharmacology and Therapeutics|December 5, 2000
Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndromeT Hirano, T Akashi, T Keira, et al.Clinical Pharmacology and Therapeutics|September 1, 1975
Interactions of levodopa with inhibitors of monoamine oxidase and L-aromatic amino acid decarboxylaseP F Teychenne, D B Calne, P J Lewis, et al.Clinical Pharmacology and Therapeutics|September 1, 1975
Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestionN L Benowitz, R T JonesPageof 941